The Summer School on Pharmaceutical Analysis (SSPA), which was an EFMC Sponsored Event in 2009, received the status of EFMC Sponsored School. SSPA is planned yearly under the auspices of the Division of Medicinal Chemistry of the Italian Chemical Society and the EFMC. The 2009 edition, held in September in Milan, focused on advanced analytical methodologies in drug development and attracted about 70 participants. SSPA 2010 will take place in June in Rimini, and will cover advanced analytical methodologies in drug quality control and preformulation.
_________________________________________________________________
EFMC is conferring every two years three Awards in order to acknowledge outstanding achievements in the field of Medicinal Chemistry. The 2010 Awards will be conferred on the occasion of the XXIst "International Symposium on Medicinal Chemistry" (EFMC-ISMC), scheduled to be held in Brussels, Belgium, September 5-9, 2010. Deadline for submission: January 31, 2010.
More information can be found on:
www.efmc.info/content.php?langue=english&cle_menus=1176113444
_________________________________________________________________
EFMC established two new Prizes, “The EFMC Prize for Young Medicinal Chemist in Industry” and “The EFMC Prize for Young Medicinal Chemist in Academia”, to acknowledge and recognize an outstanding young medicinal chemist (<35 years old) working in industry or in academia within Europe. Deadline for submission: January 31, 2010.
More information can be found on:
www.efmc.info/content.php?langue=english&cle_menus=1201086324
_________________________________________________________________
The XXIst International Symposium on Medicinal Chemistry (EFMC-ISMC 2010) will take place in Brussels, Belgium on September 5-9, 2010. This symposium traditionally attracts experts in drug research and development, in particular medicinal and synthetic chemists, combinatorial chemists, molecular modelers, pharmacologists, as well as development chemists. It is recognized worldwide as one of the leading Medicinal Chemistry meetings, as proven by its large international attendance. ISMC 2008 Vienna attracted 1400 participants, from industry and academia. Registration is open and can be done via the online registration tool on the Symposium website www.ismc2010.org
_________________________________________________________________
In 2009, EFMC launched a series of short courses. The second Short Course on Medicinal Chemistry is entitled “EFMC Safety and Attrition Workshop” and will take place in Oegstgeest, The Netherlands on April 11-14, 2010. This intensive 3 days course is intended for scientists working in the field, and the presentations will be given by senior scientists both from industry and academia.
More information is available on: www.efmc.info
Contact: administration@efmc.info
_________________________________________________________________
“Medicinal Chemistry in Europe”, the official EFMC Yearbook, will be distributed in January 2010. It is a valuable instrument for those who are interested in finding information related to the activities and composition of Member Societies, Corporate Members and on the activities and events of EFMC and its Committees.
_________________________________________________________________
The 3rd International Symposium on Advances in Synthetic and Medicinal Chemistry, organized by EFMC and ChemBridge Corporation, took place in Kiev and became despite the difficult economic situation a successful event. 300 participants from 33 different countries attended this symposium where American and Western European chemists met Eastern European scientists in the areas of synthetic and medicinal chemistry.
_________________________________________________________________
Under the theme of “Emerging Targets, Novel Candidates and Innovative Strategies”, Frontiers in Medicinal Chemistry, held in October in Barcelona, brought together medicinal chemists and related scientists in order to share exciting new results and first-time disclosures in various areas of drug discovery and development, including cancer, infectious diseases, CNS, inflammation, pain and metabolic disease. 275 registered participants attended this international meeting.
By Mark Bunnage
